Press Releases GSK plc

Equities

GSK

GB00BN7SWP63

Market Closed - London Stock Exchange Other stock markets 11:35:05 2023-12-01 am EST			5-day change	1st Jan Change
1,436.00 ^GBX	+1.17%		+0.94%	-0.11%

Dec. 01	GSK to Discontinue Manufacturing Integrilin Due to Ingredient Supply Issue	MT
Dec. 01	EMA: GLAXOSMITHKLINE IN AGREEMENT WITH EMA INFORMED GSK WILL DIS…	RE

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

GSK : Block listing Application - Form 6-K	Nov. 30	PU
New global survey finds widespread misunderstandings about shingles despite its lifetime prevalence \| GSK	Nov. 30	AQ
GSK : New global survey finds widespread misunderstandings about shingles despite its lifetime prevalence	Nov. 30	PU
GSK : Full name of shareholder(s) if different from the person(s) subject to the notification obligation, above - Form 6-K	Nov. 29	PU
GSK announces positive results from DREAMM-7 head-to-head phase III trial for Blenrep in relapsed/refractory multiple myeloma \| GSK	Nov. 28	AQ
Spleen Tyrosine Kinase (SYK) Inhibitors Pipeline, Clinical Trials Studies, Emerging Drugs, Mergers and Acquisition, Licensing, Agreements & Collaborations, and Latest News 2023 (Updated)	Nov. 22	AQ
GSK : Director/Pdmr Shareholding - Form 6-K	Nov. 21	PU
GSK announces major step towards sustainability ambitions with advancement of low carbon Ventolin programme to Phase III trials \| GSK	Nov. 21	AQ
GSK : announces major step towards sustainability ambitions with advancement of low carbon Ventolin programme to Phase III trials	Nov. 21	PU
GSK : BLOCK LISTING SIX MONTHLY RETURN - Form 6-K	Nov. 15	PU
GSK receives positive CHMP opinion recommending momelotinib for myelofibrosis patients with anaemia	Nov. 14	AQ
GSK enters agreement to obtain exclusive license for JNJ-3989 to expand the development of bepirovirsen \| GSK	Nov. 13	AQ
GSK : receives positive CHMP opinion recommending momelotinib for myelofibrosis patients with anaemia - Form 6-K	Nov. 13	PU
GSK receives positive CHMP opinion recommending momelotinib for myelofibrosis patients with anaemia \| GSK	Nov. 13	AQ
GSK and Queer Eye’s Thom Filicia Partner on Blood Cancer Awareness Initiative	Nov. 13	BU
Malaria Pipeline, Clinical Trials Studies, Emerging Drugs, Mergers and Acquisition, Licensing, Agreements & Collaborations, and Latest News 2023 (Updated)	Nov. 08	AQ
Thyroid Eye Disease Pipeline \| Clinical Trials, Key Companies - GlaxoSmithKline PLC, Abbott Laboratories, Bausch & Lomb, Horizon therapeutics, Bayer AG	Nov. 07	AQ
Wiskott Aldrich Syndrome Pipeline, Clinical Trials Studies, Emerging Drugs, Mergers and Acquisition, Licensing, Agreements & Collaborations, and Latest News 2023 (Updated)	Nov. 07	AQ
GSK enters agreement to obtain exclusive license for JNJ3989 to expand the development of bepirovirsen	Nov. 01	AQ
Glaxo: Q3 Earnings Snapshot	Nov. 01	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

GSK PLC : Q3 exceeded expectations; outlook upgraded ‘again’

November 01, 2023 at 11:02 am EDT